CCS
ALKS icon

Crosspoint Capital Strategies’s Alkermes ALKS Stock Holding History

Crosspoint Capital Strategies’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-837
Closed -$54K – 754
2015
Q2 		$54K Sell
837
-44,628
-98% -$2.73M 0.02% 341
2015
Q1 		$2.77M Buy
45,465
+45,269
+23,096% +$3.09M 1.34% 31
2014
Q4 		$11K Buy
+196
New +$9.98K ﹤0.01% 510
2014
Q2 		– Sell
-174
Closed -$8K – 507
2014
Q1 		$8K Sell
174
-110,909
-100% -$5.28M ﹤0.01% 493
2013
Q4 		$5.32M Buy
+111,083
New +$4.1M 1.77% 30

Other funds holding ALKS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Crosspoint Capital Strategies's ALKS Position: Q3 2015 in Review

Crosspoint Capital Strategies sold out of Alkermes (ALKS) in Q3 2015, closing a stake of 837 shares — an estimated $54K sold.

Crosspoint Capital Strategies first reported a position in ALKS in Q4 2013 and held it in 5 quarters. The position peaked at $5.32M in Q4 2013. 270 funds tracked by Wall St. Rank hold ALKS as of Q3 2015.

  • Crosspoint Capital Strategies reported no remaining Alkermes position as of Q3 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 837 Alkermes shares in Q3 2015, an estimated $54K.
  • Crosspoint Capital Strategies first reported a position in Alkermes in Q4 2013 and held it in 5 quarters.
  • Crosspoint Capital Strategies's Alkermes position peaked at $5.32M in Q4 2013.
  • 270 funds tracked by Wall St. Rank held Alkermes as of Q3 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2015, filed 25 Nov 2015.